QL
NVCR icon

Quarry LP’s NovoCure NVCR Stock Holding History

Quarry LP’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,313
Closed -$29.9K – 2011
2025
Q4 		$29.9K Buy
2,313
+826
+56% +$10.6K ﹤0.01% 827
2025
Q3 		$19.2K Sell
1,487
-1,413
-49% -$18.9K ﹤0.01% 1435
2025
Q2 		$51.6K Buy
+2,900
New +$50.5K 0.01% 839
2025
Q1 		– Sell
-1,346
Closed -$40.1K – 1908
2024
Q4 		$40.1K Sell
1,346
-215
-14% -$4.55K 0.01% 877
2024
Q3 		$24.4K Buy
1,561
+389
+33% +$7.05K 0.01% 1045
2024
Q2 		$20.1K Sell
1,172
-808
-41% -$14.2K 0.01% 1093
2024
Q1 		$30.9K Buy
1,980
+778
+65% +$11.4K 0.01% 706
2023
Q4 		$17.9K Buy
+1,202
New +$16.1K ﹤0.01% 808

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Quarry LP's NVCR Position: Q1 2026 in Review

Quarry LP sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 2,313 shares — an estimated $29.9K sold.

Quarry LP first reported a position in NVCR in Q4 2023 and held it in 8 quarters. The position peaked at $51.6K in Q2 2025. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Quarry LP reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 2,313 NovoCure shares in Q1 2026, an estimated $29.9K.
  • Quarry LP first reported a position in NovoCure in Q4 2023 and held it in 8 quarters.
  • Quarry LP's NovoCure position peaked at $51.6K in Q2 2025.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.